QT
PDSB icon

Quantbot Technologies’s PDS Biotechnology PDSB Stock Holding History

Quantbot Technologies’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,722
Closed -$53.6K – 1865
2023
Q1 		$53.6K Buy
8,722
+1,918
+28% +$15.7K ﹤0.01% 1240
2022
Q4 		$89.8K Buy
+6,804
New +$48K 0.01% 1162
2022
Q3 		– Sell
-4,200
Closed -$15K – 1966
2022
Q2 		$15K Buy
4,200
+3,500
+500% +$16.6K ﹤0.01% 1489
2022
Q1 		$4K Buy
+700
New +$4.35K ﹤0.01% 1551

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Quantbot Technologies's PDSB Position: Q2 2023 in Review

Quantbot Technologies sold out of PDS Biotechnology (PDSB) in Q2 2023, closing a stake of 8,722 shares — an estimated $53.6K sold.

Quantbot Technologies first reported a position in PDSB in Q1 2022 and held it in 4 quarters. The position peaked at $89.8K in Q4 2022. 80 funds tracked by Wall St. Rank hold PDSB as of Q2 2023.

  • Quantbot Technologies reported no remaining PDS Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 8,722 PDS Biotechnology shares in Q2 2023, an estimated $53.6K.
  • Quantbot Technologies first reported a position in PDS Biotechnology in Q1 2022 and held it in 4 quarters.
  • Quantbot Technologies's PDS Biotechnology position peaked at $89.8K in Q4 2022.
  • 80 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.